Rapport Therapeutics
RAPP
23.16
-0.43
-1.82%
Rapport Therapeutics
US · RAPP
#2970 by market cap
Listed 2024
23.16
-0.43
-1.82%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 14 analysts
Buy
Avg price target 68.00 +193.6%
Price target rangecurrent 23.16
Low47.00
Avg68.00
High91.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-12 | JonesTrading | -- | Buy | 82.00 |
| 2026-11-05 | Wells Fargo | -- | Buy | 47.00 |
| 2026-11-05 | UBS | -- | Buy | 64.00 |
| 2026-11-05 | H.C. Wainwright | -- | Buy | 63.00 |
| 2026-11-04 | Wells Fargo | -- | Buy | 47.00 |
| 2026-11-04 | Guggenheim | -- | Buy | 66.00 |
| 2026-10-21 | Wells Fargo | -- | Buy | 50.00 |
| 2026-10-21 | JonesTrading | -- | Buy | 82.00 |
| 2026-10-21 | Goldman Sachs | -- | Buy | 68.00 |
| 2026-10-20 | Wells Fargo | -- | Buy | 50.00 |
| 2026-10-20 | Raymond James | -- | Buy | 86.00 |
| 2026-10-20 | Citizens JMP | -- | Buy | 91.00 |
| 2026-10-20 | Guggenheim | -- | Buy | 70.00 |
| 2026-10-20 | H.C. Wainwright | -- | Buy | 66.00 |
| 2026-10-16 | Wells Fargo | -- | Buy | 51.00 |
| 2026-10-15 | Wolfe Research | -- | Buy | 50.00 |
| 2026-10-05 | Guggenheim | -- | Buy | 65.00 |
| 2026-10-01 | BTIG | -- | Buy | 75.00 |
| 2026-09-23 | William Blair | -- | Buy | -- |
| 2026-09-23 | Raymond James | -- | Buy | -- |
| 2026-09-23 | Truist Financial | -- | Buy | -- |
| 2026-09-23 | H.C. Wainwright | -- | Buy | 66.00 |
| 2026-09-22 | TD Cowen | -- | Buy | -- |
| 2026-09-22 | BTIG | -- | Buy | 75.00 |
| 2026-09-22 | Goldman Sachs | -- | Buy | 62.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Rapport Therapeutics discussion 0 comments